Company intelligence / Profile preview

Transgenic Rabbit Models

Jouy-en-Josas, Île-de-France, France

Ownership: Private
Development stage: Other

Overview

TRM provides fully integrated design and production of customized transgenic rabbit models; these models facilitate research into complex human diseases, especially where traditional mouse/rat models are insufficient; enhanced capabilities in gene targeting and speed of generating new animal lines have been been noted.

Therapeutic areas: CardiovascularOphthalmologyEndocrinologyPulmonologyInfectious DiseasesRare DiseasesHematologyOncology
Modalities: Recombinant proteinTransgenic animal modelGene knock-inGene knock-outKnock-down
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Transgenic Rabbit Models.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transgenic Rabbit Models.

Explore the full profile